PFE Pfizer Inc

  1. Stocks
  2. Healthcare
  3. NYSE: PFE

Price (delayed)

$25.92

Market cap

$147.73B

P/E Ratio

19.79

Dividend/share

$1.72

EPS

$1.31

Enterprise value

$210.48B

?
Relative Growth: Rel. Growth: 26
Relative Strength: Rel. Strength: 43
Relative Valuation: Rel. Valuation: 56
Relative Profitability: Rel. Profitability: 62

Pfizer Inc. is an American multinational pharmaceutical corporation. It is one of the world's largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United ...

Highlights
Pfizer's equity has increased by 4.2% QoQ
Pfizer's gross profit has increased by 3.1% YoY
The quick ratio has grown by 9% from the previous quarter but it has contracted by 6% YoY
The price to earnings (P/E) is 21% higher than the last 4 quarters average of 16.4 and 6% higher than the 5-year quarterly average of 18.7
Pfizer's EPS has decreased by 6% YoY and by 4.4% from the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - General
Website: https://www.pfizer.com/
Peers: MRK JNJ BMY LLY

Key stats

What are the main financial stats of PFE

PFE stock price

How has the Pfizer stock price performed over time
Intraday
-0.46%
1 week
1.25%
1 month
2.33%
1 year
8%
YTD
4.1%
QTD
-7.69%

Financial performance

How have Pfizer's revenue and profit performed over time
Revenue
$63.32B
Gross profit
$46.55B
Operating income
$7.91B
Net income
$7.49B
Gross margin
73.5%
Net margin
11.8%
The operating income has grown by 7% YoY and by 5% from the previous quarter
PFE's net margin is down by 6% YoY and by 4.8% from the previous quarter
The company's operating margin rose by 6% YoY and by 4.2% QoQ
Pfizer's net income has decreased by 5% YoY and by 3.6% QoQ

Price vs fundamentals

How does PFE's price correlate with its fundamentals

Growth

What is Pfizer's growth rate over time

Valuation

What is Pfizer stock price valuation
PFE P/E details
P/E
19.79
P/B
1.64
P/S
2.33
EV/EBIT
26.73
EV/EBITDA
14.55
EV/Sales
3.32
The price to earnings (P/E) is 21% higher than the last 4 quarters average of 16.4 and 6% higher than the 5-year quarterly average of 18.7
Pfizer's EPS has decreased by 6% YoY and by 4.4% from the previous quarter
PFE's P/B is 29% below its 5-year quarterly average of 2.3 but 2.5% above its last 4 quarters average of 1.6
Pfizer's equity has increased by 4.2% QoQ
PFE's P/S is 17% below its 5-year quarterly average of 2.8 but 6% above its last 4 quarters average of 2.2

Efficiency

How efficient is Pfizer business performance
The company's return on invested capital rose by 8% YoY and by 4.4% QoQ
Pfizer's ROS has increased by 5% YoY and by 3.3% from the previous quarter
The ROE fell by 4.5% YoY and by 3.4% QoQ
Pfizer's ROA has decreased by 2.7% from the previous quarter and by 2.7% YoY

Dividends

What is PFE's dividend history
Dividend details
DPS
$1.72
Dividend yield
6.64%
Payout ratio
131.3%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Pfizer financials performed over time
PFE's total assets is 77% greater than its total liabilities
The quick ratio has grown by 9% from the previous quarter but it has contracted by 6% YoY
The current ratio has grown by 8% from the previous quarter
PFE's debt is 28% less than its equity
The debt to equity has grown by 4.3% YoY but it has contracted by 4% from the previous quarter
Pfizer's equity has increased by 4.2% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.